Extensive Roles and Technical Advances of Middle Meningeal Artery Embolization for Chronic Subdural Hematoma

Neurol Med Chir (Tokyo). 2023 Aug 15;63(8):327-333. doi: 10.2176/jns-nmc.2023-0017. Epub 2023 Jun 8.

Abstract

Chronic subdural hematoma (CSDH) is a common pathology that typically affects the elderly in Japan, an aging society. Burr-hole irrigation is the standard treatment, but middle meningeal artery (MMA) embolization is a minimally invasive alternative. MMA embolization for CSDH has frequently been reported in recent years, and many technical innovations to improve clinical outcomes have been described. Embolic materials reaching more distally are found to avoid recurrences after MMA embolization. As a result, various studies have described the superiority of embolizing the anterior and posterior branches of the MMA, the advantages of embolic materials reaching beyond the midline, and a high degree of distal penetration using a "sugar rush technique" in which 5% soluble glucose is injected through an intermediate catheter during MMA embolization. Radiographically, reports have described the importance of a "bright falx" sign obtained by infiltrating embolic material beyond the midline and post-embolization enhancement of the dura, capsular membrane, septations, and subdural hematoma fluid as indicators of the spread of embolic materials. This review provides an overview of the current status and future challenges in MMA embolization for CSDH, focusing on technical aspects to improve clinical outcomes.

Keywords: chronic subdural hematoma; middle meningeal artery embolization.

Publication types

  • Review

MeSH terms

  • Aged
  • Dura Mater / surgery
  • Embolization, Therapeutic*
  • Hematoma, Subdural, Chronic* / surgery
  • Hematoma, Subdural, Chronic* / therapy
  • Humans
  • Meningeal Arteries / diagnostic imaging
  • Meningeal Arteries / surgery
  • Trephining